'Drunk' Delhi Woman Rams SUV Into Another Car; daughter Goes Blind in an Eye, Mother Killed

Agencies
November 11, 2018

New Delhi, Nov 11: A 38-year-old woman was killed and her daughter was seriously injured after their four-wheeler was hit by a speeding vehicle, which was allegedly being driven by an inebriated woman, in west Delhi's Punjabi Bagh area, police said on Saturday. The deceased was identified as Poonam Sardana and her daughter Chetanya (13).

The accident took place on the intervening night of Friday and Saturday.

On November 9, the police were informed about an accident on the Punjabi Bagh Flyover. Two damaged vehicles were found on the spot.

Sudhir Sardana along with his family, including Poonam and Chetanya, were returning from Chhatarpur Temple and driving towards their house in Adarsh Nagar when a vehicle bearing an Uttar Pradesh registration number lost control, jumped over the road divider and rammed their car, police said.

It was found that the erring vehicle was being driven by one Shivani Malik (22). She was accompanied by three of her friends, who allegedly had alcoholic drinks at Connaught Place, and were driving towards Gurugram, police added.

"It is suspected that Shivani was driving at a high speed. She lost control of the vehicle, and hit the divider before crossing over to the other lane and hitting Sardana's car from the rear-end," police said.

Shivani's vehicle then upturned over another car being driven by one Tarun Bajaj, who escaped with minor injuries, they added.

The injured were rushed to a hospital where Poonam Sardana (38) was declared brought dead while her 13-year-old daughter's eye was severely hurt. Poonam's cornea was used to give vision to her daughter, police said.

The accused, Shivani Malik, is a resident of Ghaziabad, Uttar Pradesh. She was allegedly inebriated and was on her way to Gurugram Club along with friends, deputy commissioner of police (west) Monika Bhardwaj said.

The accused woman works at a salon in Noida. She was arrested and a case was registered against her, officials said.

Comments

kAMAL
 - 
Tuesday, 13 Nov 2018

Indian women are considering as if they are western country women and feel proud to follow their life style.    Indian girls have started drining alcohol, dancing till late night, dressing little clothes, smoking , enjoying open sex, living with partner without marriage etc etc.  this is definately ruin our society.  However, girls of so called high society thinks this is the right way of living.  shame on you.  You are deserting your life and harm others also.   The reckless driver in this case should be penalised heavility and the amount be given to the close family of the deceased. 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 13,2020

Raipur, Mar 13: Calling Jyotiraditya Scindia a "power-hungry" leader, Chhattisgarh Minister and Congress leader TS Singh Deo on Friday said that if someone joins another party to occupy the top position of the state that he should never become a Chief Minister.

When enquired if Deo has any plans to join the BJP in the future, he quickly said that he would never be able to relate himself with the "ideology" of the party.

"People may make claims but I will never join BJP, even if I get 100 lives I will never associate with that ideology. A person who joins BJP for not being able to become Chief Minister should never become a Chief Minister," he said while speaking to media in Raipur.

"A single person does not remain as captain forever, Kapil Dev got his chance when Gavaskar was there. Currently, Virat Kohli is the captain but in T20 there are different captains. Will Kohli join Pakistan's team if he is not made the captain? This is beyond understanding."

On Wednesday, Scindia joined BJP in New Delhi in the presence of party President JP Nadda. He had resigned from Congress a day earlier after meeting Union Home Minister Amit Shah and Prime Minister Narendra Modi.

He will file his nomination for the Rajya Sabha elections on March 13.

Comments

Indian
 - 
Friday, 13 Mar 2020

May it be Scindia or some other, misusing power cheating with citizens mandate for their self benifit  "very soon the fare and best judgement from the creator will be their very soon.  No one is greatro than the creator.

 

 

For citizens well fare creator is opinion and protect always there. Hope MP people always with faith on creator.

 

 

Jai Hind !

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 3,2020

New Delhi, Jul 3: India reported the highest ever single-day spike of 20,903 COVID-19 cases in 24 hours on Friday, said the Union Ministry of Health and Family Welfare.

With these new cases, India's coronavirus tally has risen to 6,25,544 cases of which 2,27,439 patients are active cases while 3,79,892 patients have been cured/discharged/migrated.

379 more deaths due to COVID-19 were reported in the country in the last 24 hours, taking the number of deaths due to the infection to 18,213.

As per the Health Ministry, Maharashtra -- the worst-affected state from the virus -- has a total of 1,86,626 cases including 8,178 fatalities while Tamil Nadu has 98,392 coronavirus cases in the state inclusive of 1,321 fatalities.

Delhi has reported 92,175 cases so far inclusive of 2,864 patients succumbing to the virus.

The Indian Council of Medical Research on Friday said that the total number of samples tested till July 2 is 92,97,749 of which 2,41,576 samples were tested on Thursday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.